• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN SURGICAL TRI-STAPLE 2.0; STAPLE, IMPLANTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN SURGICAL TRI-STAPLE 2.0; STAPLE, IMPLANTABLE Back to Search Results
Model Number SIG30CTAVM
Medical Device Problem Code Failure to Form Staple (2579)
Health Effect - Clinical Codes Hemorrhage/Blood Loss/Bleeding (1888); Laceration(s) (1946); Perforation of Vessels (2135); Great Vessel Perforation (2152); Tissue Breakdown (2681)
Date of Event 08/06/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
D10 concomitant product: sigpshell, sig power sigpshell control shell (lot #n4l1660y).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
It was reported that during a right upper lobectomy, the reload was loaded and fired with no issues; however, when the stapler was opened, the vein began to bleed rapidly.The proximal end of the vein, closest to the apex of the stapler, appeared cut but not stapled, with approximately 2mm.The patient lost approximately 1.3 liters of blood during surgery.A thoracotomy was required to access and suture the bleeding vein, and surgical time was extended by approximately half an hour.The patient was reported to be stable at the end of the procedure, and tumor removal was successful.
 
Additional Manufacturer Narrative
Correction: b1, h6.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Additional information: d9, g3, h3, h6.H3 evaluation summary: medtronic conducted an investigation based upon all information received.The device was available for evaluation.The evaluation found no potentially contributing factors, and the sample met all related specifications.It was reported that the proximal end of the vein, closest to the apex of the stapler, appeared cut but not stapled, approximately 2 millimeters (mm).The reported issue could not be confirmed.The most likely cause could not be identified because no related problem was detected with the device.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRI-STAPLE 2.0
Common Device Name
STAPLE, IMPLANTABLE
Manufacturer (Section D)
COVIDIEN SURGICAL
60 middletown ave
north haven CT 06473
Manufacturer (Section G)
COVIDIEN SURGICAL
60 middletown ave
north haven CT 06473
Manufacturer Contact
mike bocchino
8200 coral sea st ne
mounds view, MN 55112-4391
8006464633
MDR Report Key22778219
Report Number1219930-2025-03519
Device Sequence Number21112131
Product Code GDW
UDI-Device Identifier10884521543744
UDI-Public(01)10884521543744(17)300228(10)N5C1837Y(20)03
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
K160176
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 10/24/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberSIG30CTAVM
Device Catalogue NumberSIG30CTAVM
Device Lot NumberN5C1837Y
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/06/2025
Supplement Date Received by Manufacturer08/19/2025
10/09/2025
Initial Report FDA Received Date08/11/2025
Supplement Report FDA Received Date08/20/2025
10/24/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/12/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H11
Outcome Attributed to Adverse Event Required Intervention;
Patient SexFemale
-
-